Literature DB >> 9952025

Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I).

H Furukawa1, T Yabe, K Watanabe, R Miyamoto, A Miki, T Akaza, K Tadokoro, S Tohma, T Inoue, K Yamamoto, T Juji.   

Abstract

NK cells recognize target cells that lack HLA class I molecules and lyse them, according to the 'missing self' hypothesis. It was previously reported that a TAP2-deficient patient with an HLA class I-deficiency, had a normal number of NK cells but that the lymphocytes of this patient had lost their NK activity against K562 cells. In this study, we investigated the HLA class I-recognizing NK receptor expressions and the NK and LAK activities of the lymphocytes of a TAP1-deficient patient. The patient had a normal number of NK cells. Although the lymphocytes showed LAK activity against class I expressing targets following IL-2, IL-12 and IL-15 stimulation for 3 days, neither NK nor LAK activity against targets lacking class I molecules was induced. The NK cells of the patient expressed class I-recognizing NK receptors, although the percentages of such cells were low. However, no differences were observed in the expression levels of inhibitory and activating NK receptors between lymphocytes of the patient and those of healthy controls, suggesting that the modulation of the NK receptor expression is not primarily responsible for this tolerance. These results also suggest that the lymphocytes of the patient are defective in the recognition of class I-deficient target cells in order to promote the induction of self tolerance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952025     DOI: 10.1016/s0198-8859(98)00097-4

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  18 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Natural killer cell tolerance: control by self or self-control?

Authors:  Baptiste N Jaeger; Eric Vivier
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-03-01       Impact factor: 10.005

Review 3.  Natural killer cell deficiency.

Authors:  Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-09       Impact factor: 10.793

4.  Single nucleotide polymorphisms in the FcγR3A and TAP1 genes impact ADCC in cynomolgus monkey PBMCs.

Authors:  Jonathan C Sanford; Hong Wu; Yasmina Abdiche; Julie A Harney; Javier Chaparro-Riggers; Karissa Adkins
Journal:  Immunogenetics       Date:  2017-02-03       Impact factor: 2.846

Review 5.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

6.  Molecular studies and NK cell function of a new case of TAP2 homozygous human deficiency.

Authors:  N Matamoros; J Milà; M Llano; A Balas; J L Vicario; J Pons; C Crespí; N Martinez; J Iglesias-Alzueta; M López-Botet
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

Review 7.  Natural killer cell biology: an update and future directions.

Authors:  Kerry S Campbell; Jun Hasegawa
Journal:  J Allergy Clin Immunol       Date:  2013-07-30       Impact factor: 10.793

8.  Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome.

Authors:  H Furukawa; S Murata; T Yabe; N Shimbara; N Keicho; K Kashiwase; K Watanabe; Y Ishikawa; T Akaza; K Tadokoro; S Tohma; T Inoue; K Tokunaga; K Yamamoto; K Tanaka; T Juji
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

9.  Lethal NK-mediated inflammation induced by IL-12 in the absence of polymorphic and nonpolymorphic MHC class I molecules.

Authors:  Christopher S Eickhoff; Anita R Schnapp; John E Sagartz; Daniel F Hoft
Journal:  Cytokine       Date:  2013-07-24       Impact factor: 3.861

Review 10.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.